A099430 logo

Bio Plus Co., Ltd Stock Price

KOSDAQ:A099430 Community·₩336.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

A099430 Share Price Performance

₩0
-5260.00 (-100.00%)
₩0
-5260.00 (-100.00%)
Price ₩0

A099430 Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with very low risk.

2 Risks
0 Rewards

Bio Plus Co., Ltd Key Details

₩89.2b

Revenue

₩30.2b

Cost of Revenue

₩59.0b

Gross Profit

₩42.8b

Other Expenses

₩16.2b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
270.10
66.15%
18.18%
33.2%
View Full Analysis

About A099430

Founded
2003
Employees
125
CEO
Hyun-Kyu Jung
WebsiteView website
www.bioplus.co.kr

Bio Plus Co., Ltd engages in the research and development, production, and sale of bio products in South Korea. It offers dermal fillers under the SkinPlus – Hyal, Bio+ Dew, HyalDew, DeneB Classic, Stilea, and 3-Senses brand names. The company also provides medical products, including InterBlock, an absorbable anti-adhesion barrier; Synofil, a synovial fluid replacement; and Blad-Care, a solution to temporarily improve cystitis symptoms. In addition, it offers mesotherapy products, such as skin rejuvenation products under the Kiara Reju name; Slim Slimmer, a lipolysis solution; LumiDew, a whitening solution; JuveniHill, an anti-wrinkle solution; and hair scalp care, hair treatment, hair nutrition solutions under the BelloHa and BellaChe names, as well as cosmetics comprising heparinoid essence, EGF ball, and skin care gel under the La Bella name. The company was founded in 2003 and is based in Seongnam-si, South Korea.

Recent A099430 News & Updates

Bio Plus' (KOSDAQ:099430) Dividend Will Be ₩50.00

Nov 10
Bio Plus' (KOSDAQ:099430) Dividend Will Be ₩50.00

Recent updates

No updates

Bio Plus Co., Ltd Competitors